Researchers Test Noninvasive Form of Deep Brain Stimulation on Mice
Researchers developed a method for noninvasive deep brain stimulation (DBS) that showed promise as a potential way to stimulate neurons…
Articles by Joana Fernandes, PhD
NTCELL Shows Promise as Cell Therapy for Parkinson’s Patients
Results from a Phase 1/2a clinical trial (NCT01734733) show that treatment with Living Cell Technologies Limited (LCT)’s product…
Study Reviews Use of Acadia’s Nuplazid as Treatment for Psychosis Linked to Parkinson’s Disease
Acadia Pharmaceuticals‘ Nuplazid (pimavanserin) is a reliable treatment to manage hallucinations and delusions associated with Parkinson’s disease psychosis…
FDA Reviewing ADS-5102, Possible 1st Treatment for Levodopa-induced Dyskinesia in Parkinson’s
Treatment with ADS-5102 (amantadine) significantly decreased levodopa-induced dyskinesia and off-time episodes in patients with Parkinson’s disease at three months, and maintained…
Finding Explains How Protein Aggregates Damage Neurons in Parkinson’s, Other Diseases
Researchers found that clumps of faulty protein involved in Alzheimer’s, Parkinson’s, and Huntington’s disease cause brain damage by invading and…
New Biomarkers May Help Predict Cognitive Impairment in Parkinson’s Patients, Study Suggests
Researchers have found new biomarkers that may improve the ability of clinicians to predict which patients in the early stages…
Parkinson’s Disease May Share SOD1 Protein Anomaly with ALS, Study Finds
Parkinson’s disease and amyotrophic lateral sclerosis (ALS) may have more in common than previously thought. According to a recent study,…
NeuroDerm to Present Updates on 2 Parkinson’s Therapies at Vancouver MDS Congress
Israel’s NeuroDerm will update its ND0612H and ND0701 therapies for Parkinson’s disease during the 21st International Congress of Parkinson’s…
Acorda Therapeutics to Present Update on Phase 3 Study of Inbrija In Parkinson’s Patients
Acorda Therapeutics will soon release novel data on its Phase 3 SPAN-PD trial (Study 004, NCT02240030) investigating the experimental…
Parkinson’s and Related Disorders Seen to Shorten Patient’s Lifespan by About 2 Years, Study Reports
People with Parkinson’s disease and related dementias are more likely to die younger than those of comparable age in the general…